OTIC
Otonomy Inc

5,505
Loading...
Loading...
Otonomy, Inc. is a biopharmaceutical company, which engages in the development of therapeutics for neurotology. The firm’s product pipeline includes OTIVIDEX (dexamethasone) Meniere's disease, OTIPRIO (ciprofloxacin otic suspension) acute otitis media with tubes (AOMT), OTO-313 (gacyclidine) tinnitus, OTO-413 (BDNF) hidden hearing Loss, OTO-510 (otoprotectant) prevent CIHL, OTO-6XX (hair cell regeneration) severe hearing loss. It operates under the Otiprio brand. The company was founded by Jay B. Lichter, Jeffrey Harris, Rick Friedman, and Allen F. Ryan on May 6, 2008 and is headquartered in Wilmington, DE.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A

Frequently Asked Questions

What is Market Cap of Otonomy Inc?
What is the 52-week high for Otonomy Inc?
What is the 52-week low for Otonomy Inc?
What is Otonomy Inc stock price today?
What was Otonomy Inc stock price yesterday?
What is the PE ratio of Otonomy Inc?
What is the Price-to-Book ratio of Otonomy Inc?
What is the 50-day moving average of Otonomy Inc?

Latest OTIC News

View
No OTIC news at the moment.

Advertisement|Remove ads.

Advertisement|Remove ads.